Mersana Therapeutics
IPOTargeted Therapies for Children and Adults
Cambridge, United States · $27.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Business Model
- B2B
- Website
- mersana.com
- Total Funding
- $27.0M
- Last Round
- $27.0M Series AJan 2012
- Rounds
- 1
About
Mersana Therapeutics is a clinical-stage biopharmaceutical company developing antibody-drug conjugates; acquired by Day One Biopharmaceuticals in 2025.
Summary
Mersana Therapeutics is a Biotech company based in Cambridge, United States. It has raised $27.0M in total across 1 round, most recently a $27.0M Series A round in Jan 2012. Investors include New Enterprise Associates, Fidelity Biosciences and ProQuest Investments.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2017
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...